semaglutide fda approved weight loss Approval vs Compounded Alternatives Semaglutide, also known as Ozempic,

It is the strategy most likely to produce a successful 12-month outcome

What it is: A once-weekly GLP-1 medicine for chronic weight management when combined with diet and activity How it works: Activates GLP-1 receptors in the brain and gut to reduce hunger and increase fullness What to expect: Many patients see steady weight loss over several months as the dose reaches a maintenance level Common considerations: Nausea, mild stomach discomfort, constipation, or diarrhea can occur during dose increases and usually improve with time and meal adjustments What it is: A once-weekly medicine that targets both GIP and GLP-1 receptors How it works: Adds a second pathway that further supports appetite control and metabolic health What to expect: Clinical studies have shown larger average weight reductions at higher doses compared with GLP-1 alone

Try keeping a log of how you feel throughout treatment

his book Live to Ride: Finding Joy and Meaning on a Bicycle is out in March 2024.

NOTE: This medicine is only for you